Close Menu
  • Home
  • Markets
    • Earnings
  • Banks
    • Crypto
    • Investing
  • Business
    • Retail
  • industry
    • Finance
    • Energy
    • Real Estate
  • Politics
  • Editorials
Facebook X (Twitter) Instagram
Facebook LinkedIn
Financial Market News
Subscribe Now
  • Home
  • Markets
    • Earnings
  • Banks
    • Crypto
    • Investing
  • Business
    • Retail
  • industry
    • Finance
    • Energy
    • Real Estate
  • Politics
  • Editorials
Financial Market News
You are at:Home»Posts Tagged "Pharmaceuticals" (Page 3)

Rhythm Pharmaceuticals stock hits all-time high of 104.93 USD By

By FinMar NewsAugust 28, 2025

Rhythm Pharmaceuticals stock hits all-time high of 104.93 USD Read More: Rhythm Pharmaceuticals stock hits all-time high of 104.93 USD By

Trump administration fires CDC Dir. Susan Monarez after she refuses to

By FinMar NewsAugust 28, 2025

Susan Monarez, President Donald Trump’s nominee to be the Director of the Centers for Disease Control and Prevention (CDC), testifies during her confirmation hearing before the…

FDA approves Signos glucose monitoring for weight loss

By FinMar NewsAugust 20, 2025

Woman with Signos wearable and appSource: SignosThe Food and Drug Administration on Wednesday approved the first-ever glucose monitoring system specifically for weight loss from the startup…

Eli Lilly’s Mounjaro shows similar heart health benefits as Trulicity

By FinMar NewsJuly 31, 2025

Mounjaro manufactured by Eli Lilly and Company packaging is seen in this illustration photo taken in a pharmacy in Krakow, Poland on April 9, 2024.Nurphoto |…

Space startup Varda raises $187 million to make drugs in orbit

By FinMar NewsJuly 11, 2025

Pavlo Gonchar | Lightrocket | Getty ImagesSpace startup Varda announced on Thursday that it has raised $187 million in Series C funding, led by venture capital…

RFK Jr. cuts jobs at minority health offices at HHS

By FinMar NewsApril 30, 2025

Employees of the Department of Health and Human Services (HHS) queue outside the Mary E. Switzer Memorial Building, after it was reported that the Trump administration…

FDA guts education, training division as part of RFK Jr.’s cuts

By FinMar NewsApril 9, 2025

The Food and Drug Administration has gutted a division responsible for training agency staff and outside health-care professionals on an array of key public health, regulation…

Europe’s pharma industry braces for tariffs as carve-out hopes fade

By FinMar NewsApril 2, 2025

SEIZED OZEMPIC, WEGOVY AND OTHER WEIGHT LOSS DRUGS AT JFK AIRPORT’S INTERNATIONAL MAIL FACILITY.CNBCCOPENHAGEN, Denmark — Europe’s pharmaceutical sector is bracing for the potential impact of…

Novo Nordisk’s diabetes pill Rybelsus slashes cardiovascular risk

By FinMar NewsMarch 30, 2025

Novo Nordisk on Saturday said its diabetes pill Rybelsus showed cardiovascular benefits in a late-stage trial, paving the way for it to become a new treatment…

Zepbound copycats remain online despite FDA ban

By FinMar NewsMarch 22, 2025

This week was supposed to mark the end of compounding pharmacies making copycat versions of Eli Lilly’s weight-loss drug Zepbound and its diabetes drug Mounjaro. Online,…

Previous 1 2 3 4 5 … 11 Next
Energy News

Oil prices little changed on negotiations to manage ship traffic in Strait

NUPRC seeks deeper industry collaboration to strengthen Nigeria’s energy

Trump says Exxon and Chevron made ‘too much money’ during Iran conflict

Q&A: What does China’s 15th ‘five-year plan’ for renewables mean for

Banks News

Singapore banks offload risk to private credit

Otedola Targets 51% Stake in First HoldCo

Colony Bank represented at stock exchange ceremony

Billion-dollar property collapse highlights private credit danger

Real Estate News

Lehi Real Estate Snapshot: July 2026

North Dakota Farm Real Estate Values Rise 3.8% in 2026

After Avula proposes ‘modest’ real estate tax relief, 3 Council members

HOA financial strain fuels increase in homeowner foreclosures: report

© 2026 finmar.news

Type above and press Enter to search. Press Esc to cancel.

Social Media Auto Publish Powered By : XYZScripts.com